NEW YORK (
Fresenius Medical Care Corporation
) hit a new 52-week high Thursday as it traded at $65.50 compared with its previous 52-Week high of $65.30. Fresenius Medical Care is changing hands at $65.26 with 5,971 shares traded as of 9:58 a.m. ET. Average volume has been 88,500 shares over the past 30 days.
Fresenius Medical Care has a market cap of $19.2 billion and is part of the
industry. Shares are up 12.4% year to date as of the close of trading on Wednesday.
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, offers dialysis treatment services through its clinics. As of December 31, 2009, the company provided dialysis treatment to 195,651 patients in 2,553 clinics worldwide located in approximately 35 countries. The company has a P/E ratio of 21.6, above the average health services industry P/E ratio of 20.3 and below the S&P 500 P/E ratio of 22.7.
TheStreet Ratings rates Fresenius Medical Care as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
52-week high stocks
or get investment ideas from our